An F.D.A. panel recommends Pfizer boosters for those over 65 or at high risk of severe Covid.
A key advisory panel to the Food and Drug Administration overwhelmingly rejected recommending Pfizer booster shots for most recipients of the company’s coronavirus vaccine, instead endorsing them only for people who are 65 or older or at high risk of severe Covid-19.